FDA Approves Enhertu to Treat Gastric and GEJ Adenocarcinomas

The FDA approved approved fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo/AstraZeneca) for adults with ...

JANUARY 29, 2021